Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Emerg Infect Dis ; 24(11): 1998-2002, 2018 11.
Artículo en Inglés | MEDLINE | ID: mdl-30334702

RESUMEN

Cryptococcus gattii traditionally infects immunocompetent hosts and causes devastating pulmonary or central nervous system disease. However, this infection rarely occurs in patients infected with HIV. We report 3 cases of HIV-associated C. gattii complex infections in the southeastern United States. Detection of C. gattii in HIV-infected patients in this region warrants increased awareness of this threat to ensure appropriate diagnosis and treatment to optimize patient outcomes.


Asunto(s)
Cryptococcus gattii/aislamiento & purificación , Infecciones por VIH/diagnóstico por imagen , VIH/aislamiento & purificación , Meningitis Criptocócica/diagnóstico por imagen , Adulto , Infecciones por VIH/complicaciones , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/virología , Humanos , Masculino , Meningitis Criptocócica/complicaciones , Meningitis Criptocócica/tratamiento farmacológico , Meningitis Criptocócica/microbiología , Persona de Mediana Edad , Sudeste de Estados Unidos , Tomografía Computarizada por Rayos X
2.
Int J Antimicrob Agents ; 62(1): 106842, 2023 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-37160242

RESUMEN

BACKGROUND: This study compared dalbavancin with standard of care (SOC) for patients with Staphylococcus aureus bacteraemia (SAB) who were unable to receive outpatient parenteral antimicrobial therapy (OPAT). METHODS: This retrospective cohort compared re-admission rates related to the index infection between patients treated with dalbavancin or SOC for SAB. Patients aged ≥18 years seen by the infectious diseases consult service who had received at least one dose of dalbavancin or at least 1 week of SOC parenteral antibacterials as directed therapy for SAB at the time of discharge were included. The SOC group consisted of patients transferred from the main hospital to one of the post-acute care facilities to complete parenteral antibacterials. The primary outcome was re-admission rate within 30 days of completion of therapy. Secondary outcomes included re-admission rate within 90 days of completion of therapy and adherence to the antibacterial regimen. RESULTS: Twenty-seven patients received dalbavancin and 27 patients received SOC. Baseline demographics were comparable between groups, although more patients in the SOC group had indwelling prostheses or hardware (4% vs 22%). The majority of SAB was caused by methicillin-susceptible S. aureus (56% vs 59%). Re-admission rates for the dalbavancin group were similar to those for the SOC group within 30 days (15% vs 22%; P=0.484) and 90 days (19% vs 22%; P=0.735) of completion of therapy. Adherence to the antibacterial regimen was significantly higher among patients treated with dalbavancin compared with SOC (85% vs 44%; P<0.001). CONCLUSIONS: Dalbavancin offers similar clinical outcomes to SOC for patients with SAB who are unable to receive OPAT.


Asunto(s)
Bacteriemia , Staphylococcus aureus Resistente a Meticilina , Infecciones Estafilocócicas , Humanos , Adolescente , Adulto , Infecciones Estafilocócicas/tratamiento farmacológico , Staphylococcus aureus , Pacientes Ambulatorios , Bacteriemia/tratamiento farmacológico , Bacteriemia/microbiología , Estudios Retrospectivos , Nivel de Atención , Teicoplanina/efectos adversos , Antibacterianos
3.
Ther Adv Infect Dis ; 9: 20499361211066363, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35070297

RESUMEN

SARS-CoV-2 may activate both innate and adaptive immune responses ultimately leading to a dysregulated immune response prompting the use of immunomodulatory therapy. Although viral pneumonia increases the risk of invasive fungal infections, it remains unclear whether SARS-CoV-2 infection, immunomodulatory therapy, or a combination of both are responsible for the increased recognition of opportunistic infections in COVID-19 patients. Cases of cryptococcosis have previously been reported following treatment with corticosteroids, interleukin (IL)-6 inhibitors, and Janus kinase (JAK) inhibitors, for patients with autoimmune diseases, but their effect on the immunologic response in patients with COVID-19 remains unknown. Herein, we present the case of a patient with COVID-19 who received high-dose corticosteroids and was later found to have cryptococcosis despite no traditional risk factors. As our case and previous cases of cryptococcosis in patients with COVID-19 demonstrate, clinicians must be suspicious of cryptococcosis in COVID-19 patients who clinically deteriorate following treatment with immunomodulatory therapies.

4.
IDCases ; 20: e00747, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32300526

RESUMEN

Pleural effusions and empyemas caused by Capnocytophaga spp. are uncommon with few cases previously reported. Here, we present the case of a 62-year-old man with untreated chronic lymphocytic leukemia (CLL) complicated by a pleural empyema caused by C. ochracea. The route of acquisition was likely the result of aspiration of C. ochracea coupled with the immune defects associated with untreated CLL.

5.
Adv Emerg Nurs J ; 41(4): 306-315, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31687994

RESUMEN

Up to 30% of patients report at least one antibiotic allergy, but oftentimes these antibiotic allergies are misdiagnosed. In fact, of the 10% of patients reporting penicillin allergies, 90%-98% are not truly allergic. In an era of increasing antibiotic resistance coupled with a limited number of new antibiotics, evaluating antibiotic allergies is critical in providing optimal patient care. Differentiating adverse drug reactions from antibiotic allergies may seem like a daunting task for clinicians and providers, especially in the emergency department, where decisions are made quickly. However, a systemic approach, including medical record review coupled with patient and/or family interview, is vital in managing patients with antibiotic allergies. Inappropriate, alternative antibiotics are frequently chosen due to patient allergies, and data suggest higher rates of broad-spectrum antibiotic use, antibiotic resistance, and poor outcomes as a result. Herein, we review antibiotic selection in patients reporting antibiotic allergies in the emergency department.


Asunto(s)
Antibacterianos/efectos adversos , Hipersensibilidad a las Drogas/terapia , Servicio de Urgencia en Hospital/organización & administración , Diagnóstico Diferencial , Hipersensibilidad a las Drogas/diagnóstico , Interacciones Farmacológicas , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Humanos
6.
Nurse Pract ; 43(4): 38-44, 2018 Apr 19.
Artículo en Inglés | MEDLINE | ID: mdl-29528880

RESUMEN

Fever is a common clinical sign encountered in hospitalized patients and often represents the cardinal sign of infectious processes. However, a number of noninfectious etiologies causing fever should be considered prior to initiating broad-spectrum antibiotic therapy. Reducing unnecessary antibiotic use is crucial in an era of increasing resistance.


Asunto(s)
Fiebre/etiología , Adulto , Antibacterianos/uso terapéutico , Farmacorresistencia Microbiana , Fiebre/tratamiento farmacológico , Humanos
7.
Open Forum Infect Dis ; 5(7): ofy163, 2018 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-30038930

RESUMEN

In this brief report, we describe a 76-year-old patient with thymoma who underwent craniotomy for a left parietal lobe mass with pathologic findings consistent with Toxoplasma gondii encephalitis in the absence of any features of thymoma with immunodeficiency/Good's syndrome. His clinical course suggested likely Toxoplasma reactivation.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA